Publications by authors named "Suruchi Shrestha"

Claim this Profile
M
Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Gautam Adhikary, Suruchi Shrestha, Warren Naselsky, John J Newland, Xi Chen

Mol Carcinog· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype.
Warren Naselsky, Gautam Adhikary, Suruchi Shrestha, Xi Chen, Geraldine Ezeka

Mol Carcinog· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype.
Xi Chen, Gautam Adhikary, Suruchi Shrestha, Wen Xu, Jeffrey W Keillor

Mol Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTL6A suppresses p21 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype.
Suruchi Shrestha, Gautam Adhikary, Warren Naselsky, Wen Xu, Joseph S Friedberg

Oncogenesis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.
McKayla Mickle, Gautam Adhikary, Suruchi Shrestha, Wen Xu, Richard L Eckert

Mol Carcinog· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACTL6A suppresses p21 expression to enhance the epidermal squamous cell carcinoma phenotype.
Suruchi Shrestha, Gautam Adhikary, Wen Xu, Sivaveera Kandasamy, Richard L Eckert

Oncogene· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic retroperitoneal cyst in an adult male.
Ashesh Kumar Jha, Suruchi Shrestha, Sanjay Sharma

Urol Ann· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial.
Budd A Tucker, Cathryn M Cranston, Kristin A Anfinson, Suruchi Shrestha, Luan M Streb

Transl Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis